𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bosutinib: A Review of Its Use in Patients with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia

✍ Scribed by Syed, Yahiya Y.; McCormack, Paul L.; Plosker, Greg L.

Book ID
121566348
Publisher
Springer International Publishing AG
Year
2014
Tongue
English
Weight
408 KB
Volume
28
Category
Article
ISSN
1173-8804

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Outcome of patients with Philadelphia ch
Outcome of patients with Philadelphia chromosome-positive chronic myelogenous leukemia post-imatinib mesylate failure
✍ Hagop Kantarjian; Susan O'Brien; Moshe Talpaz; Gautam Borthakur; Farhad Ravandi; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 150 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. The prognosis of patients with chronic myelogenous leukemia (CML) after failure of imatinib mesylate therapy is not well documented. ## METHODS. The outcome of 420 patients with CML post‐imatinib failure (resistance‐recurrence in 374; toxicities in 46) were reviewed in

Thiotepa for the treatment of thrombocyt
Thiotepa for the treatment of thrombocythemia in patients with Philadelphia chromosome positive chronic myelogenous leukemia
✍ Edgardo J. Rodriguez-Monge; Jorge E. Cortes; Susan O'Brien; Moshe Talpaz; Hagop πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 3 views

## Background: Patients with chronic myelogenous leukemia (cml) occasionally experience persistent thrombocythemia despite having adequate white blood cell (wbc) counts. trimethylenethiophosphoramide (thiotepa) is an alkylating agent that significantly inhibits platelet production. ## Methods: Th

Chromosomal abnormalities in Philadelphi
Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase
✍ Jorge Medina; Hagop Kantarjian; Moshe Talpaz; Susan O'Brien; Guillermo Garcia-Ma πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 107 KB

## Abstract ## BACKGROUND Anecdotal cases of chromosomal abnormalities in Philadelphia chromosome (Ph)‐negative metaphases have been reported in patients with chronic myelogenous leukemia (CML) in the chronic phase during treatment with interferon and, more recently, with imatinib. This phenomenon